US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer’s Disease: Implications for Global Drug Development

Drug development guidelines from regulatory authorities provide important information to sponsors on requirements for clinical evidence needed to support approval of new drugs. In the field of Alzheimer’s disease (AD), recently published guidelines are available from EU, US, and Japanese regulatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Morant, Anne Vinther, Vestergaard, Henrik Tang, Lassen, Anders Blædel, Navikas, Vaidrius
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359941/
https://www.ncbi.nlm.nih.gov/pubmed/32043310
http://dx.doi.org/10.1111/cts.12755

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359941/
https://www.ncbi.nlm.nih.gov/pubmed/32043310
http://dx.doi.org/10.1111/cts.12755

Ejemplares similares